Rising Cases of Child Leprosy Challenge India's Goal of Elimination by 2027

Gist India recorded 3,832 new child leprosy cases in 2025-26, exceeding its national target by over 90%. Worryingly, 37 of these children presented with Grade-2 disability G2D at the time of diagnosis, indicating delayed detection and active community transmission. This spike in pediatric infections severely challenges India's National Strategic Plan for Leprosy 2023-27, which aims to interrupt transmission at the district level by 2027. For UPSC aspirants, understanding these epidemiological markers—child cases as proof of recent transmission and G2D as proof of systemic delays—is crucial for analyzing India's healthcare governance and disease elimination strategies. Background Leprosy Hansen's Disease is a chronic bacterial infection caused by Mycobacterium leprae that primarily affects the skin and peripheral nerves. It spreads through prolonged, close contact with an untreated person and is fully curable with multidrug therapy MDT . The National Leprosy Eradication Programme NLEP is the nodal central initiative driving active case detection, household contact surveys, and targeted campaigns, operating under the Union Health Ministry. India is currently executing the National Strategic Plan for Leprosy 2023-27 . Its defining goal is to interrupt disease…